BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cell Industry Data | 3 Attributes that Make BioInformant Unique
Stem cell industry data

Stem Cell Industry Data | 3 Attributes that Make BioInformant Unique

November 12, 2018 By Cade Hildreth (CEO) Leave a Comment

BioInformant specializes in global strategic reports for the stem cell industry. As a specialty research company, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth.

Discover class-defining bioproduction tools.

3 Attributes that Distinguish BioInformant’s Stem Cell Industry Data

1) We are the only market research company that has served the stem cell sector since it emerged

Founded in 2006 in Washington, DC, by Cade Hildreth, our singular focus on the stem cell industry allows us to produce data that enables you to better understand your markets, competitors, and customers.

While other publishers are often broad-scale publishers that cover a range of industry topics, we specialize in stem cell industry data.  In contrast to other research firms, BioInformant has been collecting data on the stem cell industry for the past 12 years. This means we have numerous 5-year periods for which we made stem cell industry projections and can compare our “projected” results to what “actually” occurred within the industry.

bitbio

When choosing a provider of stem cell market intelligence, you should choose a research firm which has been tested and validated by both the market and the test of time.

2) BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CIRM, Xconomy, AABB, and Vogue Magazine.

When choosing a provider of stem cell market intelligence, you should choose one that is widely trusted and referenced. Selecting a market research provider who is referenced by the media is a way to screen for authority, accuracy, and quality, because prominent news outlets require high-quality sources.

Pluristyx

Unfortunately, all too many market research firms outsource report writing to low-cost providers overseas who know little (if anything) about the field and produce reports of very poor quality and relevancy.

In contrast, BioInformant was founded 12 years ago and is headquartered near Washington, DC, to be in proximity to the National Institutes of Health (NIH), the U.S. FDA, and the Maryland Biotech Corridor. We attend stem cell industry conferences across the U.S. and worldwide, chairing and presenting at many of them, and serve industry leading clients that include GE Healthcare, Goldman Sachs, PerkinElmer, Merck, and more.

Most importantly, our stem cell industry research is widely cited by news outlets that include the Wall Street Journal (WSJ), Nature Biotechnology, Medical Ethics, CIRM, Xconomy, AABB, and Vogue Magazine.

iPSC-derived cardiomyocte therapy

BioInformant Logo - As Cited By

3) Our management team comes from a Bioinformatics background – the science of collecting and analyzing complex genetic codes

A third aspect that sets BioInformant apart is that our leadership team comes from a “Bioinformatics” background – the science of collecting and analyzing complex genetic codes. The field of Bioinformatics involves developing tools for managing and analyzing large quantities of biological data, such as the complete set of genes within a cell (Genomics), the complete set of proteins in a cell (Proteomics), and the complete set of compounds or substrates that are formed through enzymatic reactions within living systems (Metabolomics).

All of these areas involve huge, complex data-sets that must be examined in order to identity critical information. We are trained in applying these advanced research techniques to the field of market research.

It is this expertise in “Bioinformatics” from which we derived our company name, BioInformant. 

Our skill set in Bioinformatics makes us uniquely positioned to:

  • Define scope, definitions, and boundaries for the stem cell industry
  • Collect relevant data from within this expansive system
  • Extract relevant and critical information
  • Identify key trends for purposes of predicting future activity

Additionally, we are uniquely suited to managing complex search queries within large global databases. Within the stem cell industry, this allows us to derive critical trend rate data from scientific publication databases, clinical trial databases, patent databases, grant funding databases, public blood/cell/tissue registries, transplant registries, and more.

In summary, Bioinformatics is an interdisciplinary field that develops methods and tools for processing complex biological data, while Market Research is an interdisciplinary field that develops methods and tools for analyzing complex industry data. When performed effectively, these fields share most of the same techniques.

About BioInformant

As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

To view BioInformant products, visit our Shop.

5/5 - (1 vote)

Filed Under: Stem Cells Tagged With: bioinformant, bioinformatics, market intelligence

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.